ATE76296T1 - Pharmazeutische zusammensetzung zur behandlung von akuter myocardischer ischaemie. - Google Patents

Pharmazeutische zusammensetzung zur behandlung von akuter myocardischer ischaemie.

Info

Publication number
ATE76296T1
ATE76296T1 AT85200159T AT85200159T ATE76296T1 AT E76296 T1 ATE76296 T1 AT E76296T1 AT 85200159 T AT85200159 T AT 85200159T AT 85200159 T AT85200159 T AT 85200159T AT E76296 T1 ATE76296 T1 AT E76296T1
Authority
AT
Austria
Prior art keywords
treatment
pharmaceutical composition
acute myocardial
myocardial ischaemia
ischaemia
Prior art date
Application number
AT85200159T
Other languages
English (en)
Inventor
Giuseppe Prino
Marisa Mantovani
Riccardo Niada
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Application granted granted Critical
Publication of ATE76296T1 publication Critical patent/ATE76296T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT85200159T 1984-02-16 1985-02-11 Pharmazeutische zusammensetzung zur behandlung von akuter myocardischer ischaemie. ATE76296T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8419645A IT1206341B (it) 1984-02-16 1984-02-16 Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
EP85200159A EP0152148B1 (de) 1984-02-16 1985-02-11 Pharmazeutische Zusammensetzung zur Behandlung von akuter myocardischer Ischämie

Publications (1)

Publication Number Publication Date
ATE76296T1 true ATE76296T1 (de) 1992-06-15

Family

ID=11160049

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85200159T ATE76296T1 (de) 1984-02-16 1985-02-11 Pharmazeutische zusammensetzung zur behandlung von akuter myocardischer ischaemie.

Country Status (9)

Country Link
US (1) US4693995A (de)
EP (1) EP0152148B1 (de)
JP (1) JPH0649651B2 (de)
AT (1) ATE76296T1 (de)
AU (1) AU585495B2 (de)
BE (1) BE901737A (de)
CH (1) CH662509A5 (de)
DE (1) DE3505359C2 (de)
IT (1) IT1206341B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170214B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per la cura delle arteriopatie periferiche
IT1190313B (it) * 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
NZ222051A (en) * 1986-10-06 1990-07-26 Univ Virginia Solution containing adenosine or hypoxanthine and optionally ribose for heart protection during surgery
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
US6699985B2 (en) * 1991-08-21 2004-03-02 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
IT1252174B (it) * 1991-12-09 1995-06-05 Crinos Industria Farmaco Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento
EP0678029A1 (de) * 1993-01-13 1995-10-25 BURCOGLU, Arsinur Verfahren zum gebrauch von poly-, oligonukleotiden und deren derivate für die behandelung von verschiedenen krankheitsstadien
US5852000A (en) * 1993-08-25 1998-12-22 Otsuka Pharmaceutical Factory, Inc. Cardiac rehabilitation agent
CN1113647A (zh) * 1993-08-25 1995-12-20 株式会社大制药工场 心脏恢复剂
EP1202750A4 (de) * 1997-04-28 2002-10-16 Arsinur Burcoglu Verfahren zur behandlung von hiv-infektionen und von deren opportunistischen infektionen
US7252818B2 (en) * 1998-07-24 2007-08-07 Cardiovascular Biotherapeutics, Inc. Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
EP1147777A1 (de) 2000-04-18 2001-10-24 Crinos Industria Farmacobiologica S.p.A. Kombination von Defibrotid und G-CSF und ihre Verwendung zur Aktivierung der hämatopoiestischen Vorläuferzellen
EP1325962A1 (de) * 2001-12-17 2003-07-09 Gentium S.p.A. Methode zur Bestimmung der biologischen Aktivität von Defibrotide
EP1495702A1 (de) 2003-07-10 2005-01-12 Nestec S.A. Vorrichtung zur Extraktion einer Kartusche
ITMI20031714A1 (it) * 2003-09-05 2005-03-06 Gentium Spa Formazioni ad azione antitumorale.
AU2006222045B2 (en) * 2005-03-03 2011-10-20 Gentium Spa Oligodeoxyribonucleotides of 4000-10000 Dalton for treating tumors
EP1872787A1 (de) * 2006-06-27 2008-01-02 Gentium S.p.A. Verwendung von Defibrotide als Heparanasehemmer
EP1982722A1 (de) * 2007-04-16 2008-10-22 Gentium S.p.A. Verwendung von Oligotid zur Behandlung von Nierenerkrankungen
EP2103689A1 (de) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetische Phosphodiester-Oligonukleotide und deren therapeutische Verwendungen
IT1406068B1 (it) 2010-07-22 2014-02-06 Medestea Int Spa Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego
DE102010039631A1 (de) 2010-08-22 2012-02-23 Ulrich Schubert Pharmazeutische Zusammensetzungen mit immunmodulatorischen Eigenschaften
ES2694239T3 (es) 2010-11-12 2018-12-19 Gentium S.R.L. Defibrótido para su uso en profilaxis y/o tratamiento de la enfermedad de Injerto contra huésped (GVHD)
RU2627177C2 (ru) 2012-06-22 2017-08-03 Джентиум С.Р.Л. Способ определения биологической активности дефибротида, основанный на применении эуглобулина
EP3026122A1 (de) 2014-11-27 2016-06-01 Gentium S.p.A. Zellenbasiertes Verfahren zur Bestimmung der Wirksamkeit von Defibrotid
WO2019028340A1 (en) 2017-08-03 2019-02-07 Jazz Pharmaceuticals Ireland Limited FORMULATIONS COMPRISING A HIGH CONCENTRATION NUCLEIC ACID
US11571440B2 (en) 2018-04-12 2023-02-07 Jazz Pharmaceuticals Ireland Limited Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
WO2020118165A1 (en) 2018-12-07 2020-06-11 Jazz Pharmaceuticals Ireland Limited Subcutaneous delivery of high concentration formulations
EP4110287A1 (de) 2020-02-28 2023-01-04 Jazz Pharmaceuticals Ireland Limited Abgabe von niedrigviskosen formulierungen
WO2021212055A1 (en) 2020-04-17 2021-10-21 Jazz Pharmaceuticals Ireland Limited Defibrotide treatment for the prevention of organ rejection and injury
TW202308659A (zh) 2021-05-06 2023-03-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 用於急性呼吸窘迫症候群之治療及預防的去纖維蛋白多核苷酸

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899481A (en) * 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali

Also Published As

Publication number Publication date
EP0152148A3 (en) 1987-04-29
DE3505359C2 (de) 1994-01-20
BE901737A (fr) 1985-05-29
IT8419645A0 (it) 1984-02-16
AU3878785A (en) 1985-08-22
JPS60188323A (ja) 1985-09-25
JPH0649651B2 (ja) 1994-06-29
DE3505359A1 (de) 1985-08-22
AU585495B2 (en) 1989-06-22
EP0152148B1 (de) 1992-05-20
IT1206341B (it) 1989-04-14
CH662509A5 (it) 1987-10-15
EP0152148A2 (de) 1985-08-21
US4693995A (en) 1987-09-15

Similar Documents

Publication Publication Date Title
ATE76296T1 (de) Pharmazeutische zusammensetzung zur behandlung von akuter myocardischer ischaemie.
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
UA19303A (uk) Спосіб одержаhhя похідhих 2-аhіліhопіримідиhу
DE69109560D1 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
FR2757522B1 (fr) Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
MY101784A (en) Novel pharmacological compounds
NO165237C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamido-indanylforbindelser.
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
DE19475001I2 (de) Anthelminthische Wirkstoffkombinationen.
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
ATE158947T1 (de) Hautregenerierende kosmetische zusammensetzung
BR9707770C1 (pt) Tifluzamida com eficácia aperfeiçoada
RU94040865A (ru) Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью
NO166280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n'-disubstituerte ureaer.
RU94046312A (ru) Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные
ATE116130T1 (de) Mittel zur anregung des haarwuchses.
IT8619288A0 (it) Formulazioni farmaceutiche iniettabili di principi attivi adattivita' anestetica generale.
BG47642A3 (bg) Микробициден състав и метод за борба с вредни микроорганизми
BG90609A (bg) Производни на пирола, методи за получаване и приложение
ES2039436T3 (es) Un procedimiento para preparar una composicion farmaceutica.
ATE49958T1 (de) Pharmazeutische zusammensetzungen mit immunodepressivwirkung.
FR2567756B1 (fr) Nouvelles compositions pharmaceutiques contenant comme ingredient actif l'acetyl-10 triacetoxy-1,8,9 anthracene
SE8700829L (sv) Farmaceutisk komposition